Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fudosteine in hypertension with obstructive sleep apnea
ChiCTR-TRC-13003690Phase 4Completed
- Sponsor
- Jiangsu Geriatric Hospital
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fudosteine in hypertension (HTN) and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Jiangsu Geriatric Hospital. Primary endpoints: blood pressure and flow-mediated dilation of the brachial artery. Started Nov 2013; status: completed.
02
Drugs
fudosteine
03
Conditions
hypertension (HTN)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR-TRC-13003690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003690.